Clinical characterization and treatment of triple negative breast cancer / 国际肿瘤学杂志

ABSTRACT

Triple negative breast cancers (TNBC) are a subtype of breast cancer characterized by negative expressions of estrogen receptor, progesterone receptor, and Her2/neu. Compared with other breast cancers, TNBC displays distinct clinic pathological features and prognosis, attracting much attention from oncology researchers. This review highlights the recent advances in the clinical characterization and treatment of TNBC.